AMGROS I/S has floated a tender for Contract notice: Pharmaceutical products. The project location is Denmark and the tender is closing on 14 Aug 2018. The tender notice number is 293549-2018, while the TOT Ref Number is 24812383. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : Denmark

Summary : Contract notice: Pharmaceutical products

Deadline : 14 Aug 2018

Other Information

Notice Type : Tender

TOT Ref.No.: 24812383

Document Ref. No. : 293549-2018

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : AMGROS I/S
Office Name: Amgros I/S
Address: Dampfærgevej 22
Town: Copenhagen
Postal Code: 2100
Contact Point: Flemming Sonne

Phone: +45 88713000
Fax: +45 88713008
Denmark
Email :udbud@amgros.dk
URL :http://www.amgros.dk

Tender Details

Object of the contract
Pharmaceutical products

Description: Contract notice: Pharmaceutical products

Authority Type: Body governed by public law
Contact Nature: Supplies
Procedure: Open procedure
Document: Contract notice
Regulation: European Union, with participation by GPA countries
Award criteria: Lowest price
CPV code: 33600000, 33600000, 33600000
CPV Description: Pharmaceutical products.

Amgros 2018-1.807.a.

Amgros is a partnership with the 5 regions as stakeholders. In order to provide stakeholders' hospital pharmacies with drugs and the resale of individual stakeholders to the Faroe Islands and Greenland, Amgros I / S wishes to enter into framework agreements for the medicinal products listed in Section II.2.4. The framework agreements are non-exclusive. Amgros I / S reseller lowerthe funds for hospital pharmacies to Amgros I / S 'purchase price with an additional fee. Framework agreements are entered without specification, and hospital pharmacies in the regions are not obliged to apply Amgros' framework agreements.

Main Site: Place of delivery is the address of Amgros at the address (hospital pharmacy or affiliated locations).

The tender number includes the following medicines:

Offer No: 1,

ATC Code: J05AX18,

Generic name: Letovovir,

Dispensing form: Tablets,

Strength: 240 mg,

Unit value: 480 mg,

Quantity in units: 1.

Supply No: 1,

ATC Code: J05AX18,

Generic Name: Surveillance,

Dispensing Form : Tablets,

Strength: 480 mg,

Unit value: 480 mg,

Quantity in units: 1.

The above medicines are offered independently of the drugs under the remaining tender numbers.

Each tender number is considered a sealsolid agreement. A supplier will thus be able to bid on one or more or all tender numbers and assignment is made separately for each tender number. Reference is made to the terms of reference, including the submission of tenders under the individual tender numbers. "The term" quantity in units "indicates a number. This is because the drugs under the tender number are new drugsr without historical consumption, and therefore it is not possible to estimate expected consumption in the context of the conclusion of the framework agreement. The number should therefore not be considered to be an expected consumption, but is only used to draw attention to the fact that a more fair estimate will be given in connection with the conclusion of the framework agreement. Reference is made to the terms of the tender terms. 3.6 and frameclause of the agreement. 2. The pharmaceuticals must have a marketing authorization valid for Denmark no later than 24.9.2018 at 12:00. Furthermore, at the time of the expiry of the deadline and during the duration of the framework agreement, the supplier shall be authorized to manufacture, import or wholesale pharmaceutical drugs within the EU /E0S.

Leveranders who wish to bid must apply the standard formular for the Single European Public Procurement Document (ESPD) to issue a declaration regarding the mandatory grounds for exclusion in section 135-136 of the Procurement Act (Act No. 1564 of 15 December 2015 with amendments). Further information on the completion and use of ESPD in the procurement process can be found in the guide provided by Amgros and in the Competition and Consumer Agency's "Guide to the Common EuropeThe successful tenderer (s) for which Amgros intends to award the framework agreement must, before the award, have made documentation available to Amgros in so far as the mandatory grounds for exclusion, cf. section 152 - 153 of the Procurement Act. Amgros can not exclude a supplier who is covered by one or more of the mandatory grounds for exclusion in the tenderSection 135-136, safely, the supplier can provide sufficient evidence that the supplier is, in any case, palpable, cf. section 138 of the Procurement Act. Amgros reserves the right to carry out such a self-cleaning process, safely if the mat is relevant.

No information required. II.2.3. Notes that an overview of places of delivery is available on Amgros' Supplier--and Procurement Portal, https://levportal.amgros.dk The overview is updated, as soon as possible, changes are made.

In relation to item no. II.2.4 notes that Amgros has considered whether the tender group can be further subdivided. Amgros has realized that this is not the case in the light of considerations of economies of scale that will not be realized by a further breakdown as well as costs and patientsecurity considerations related to the following contract and drug handling. II.1.5 and point II.2.6 noted that the estimated value in section. II.1.5 is the total estimated value of all tender numbers (lots) in the duration of the framework agreement incl. possibility of extension, cf. II.2.7. In section II.2.6 is the estimated value of each tender number incl. possibility-for extension specified, cf. II.2.7.

It should also be noted that the estimated value is based on historical consumption and that the actual purchase may therefore differ materially, cf. II.2.4, Item No. of the Terms and Conditions. 3.6 and the Framework Agreement Item. 2. Quotation of the tender documents must be made in the tender system, cf. the terms and conditions of the tender.

Access to tender bsuggests that the company has been established as a user of Amgros' procurement system. There may be some processing days associated with user creation, and it is therefore inconceivable for any bidders to do so in good time. Reference is made to information relating to the procurement system, including the user guide. IV.2.4 notes that some parts of the offer may also be available-English. Reference is made to the terms of the tender terms. 4.1.

In relation to point VI.2 noted that electronic invoicing is required
Internet address (URL): http://www.amgros.dk

Documents

 Tender Notice